期刊文献+

原发性中枢神经系统淋巴瘤预后相关因素研究进展

Advances in relevant prognostic factors of primary central nervous system lymphoma
原文传递
导出
摘要 原发性中枢神经系统淋巴瘤(PCNSL)是一种少见的结外恶性淋巴瘤,好发于免疫缺陷人群,但近年来在免疫功能正常人群中发病率逐年提高。其临床治疗缓解期短,易复发,预后不佳。研究发现PCNSL的预后相关因素包括:年龄、体力状态、放化疗的方式、初治对糖皮质激素的反应、组织病理和分子生物学标志等。 Primary central nervous system lymphoma (PCNSL) is a rare type of malignant lymphoma which originates in the central nervous system without spreading to other systems. It is more predisposable to immunodeficient individuals. However, an increase in the incidence of PCNSL has been also observed in the healthy population in recent years. PCNSL has short phase of clincal release, and easy to relapse with poor prognosis. Some studies have shown that relative prognostic factors were associated with age, performance status, the radiotherapy and chemotherapy modalities, the response to early adminstration of the glucocorticoid, tissue pathologic type and the molecular biologic marks.
出处 《白血病.淋巴瘤》 CAS 2009年第11期694-696,共3页 Journal of Leukemia & Lymphoma
关键词 中枢神经系统 淋巴瘤 预后 Central nervous system Lymphoma Prognosis
  • 相关文献

参考文献35

  • 1Ferreri A J, Abrey LE, Blay JY, et al. Summary statement on primary central nervous system lymphomas from the eighth international conference on malignant lymphoma. J Clin Oncol, 2003, 21: 2407 -2414.
  • 2Kadan-Lottick NS, Skluzacek MC, Gumey JG. Decreasing Incidence Rates of Primary Central Nervous System Lymphoma. Cancer, 2002, 95: 193-202.
  • 3Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance,epidemiology, and end results analysis.Cancer, 2002, 95: 1504-1510.
  • 4Ponzoni M, Berger F, Chassange Clement C, et al. Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas. Br J Haematol, 2007, 138: 316-323.
  • 5Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med, 2002, 346: 1937-1947.
  • 6Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large-B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 2004, 103: 275-282.
  • 7Oren L, Lisa M, Daniel A, et al. Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. Cancer, 2008, 112: 151-156.
  • 8Braaten KM, Betensky RA, de Leval L, et al. Bcl-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res, 2003, 9: 1063-1069.
  • 9Lin CH, Kuo KT, Chuang SS, et al. Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of eentral nervous system origin and peripheral nodal origin. Clin Cancer Res, 2006, 12:1152-1156.
  • 10Cady FM, O'Neill BP, Law ME, et al. Del (6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. Clin Oncol, 2008, 26:4814-4819.

二级参考文献25

  • 1胡毅,冯奉仪,石远凯,周立强,顾大中,王奇璐.原发性中枢神经系统淋巴瘤28例临床分析[J].中华肿瘤杂志,2004,26(6):375-378. 被引量:22
  • 2陈兴,张智民,陆小明.原发性中枢神经系统淋巴瘤32例临床分析[J].江苏医药,2005,31(11):820-822. 被引量:3
  • 3徐兵河 顾大中.中枢神经系统恶性淋巴瘤[A].王奇璐主编.恶性淋巴瘤的诊断与治疗[C].北京:北京医科大学中国协和医科大学联合出版社,1997.346.
  • 4Poortmans P M,Kluin-Nelemans H C,Haaxma-Reiche H,et al.High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma:European Organization for Research and Treatment of Cancer Lymphoma Group Phase Ⅱ Trial20962[J].J Clin Oncol,2003,21(24):4483-4488.
  • 5Batchelor T,Carson K,O'Neill A,et al.Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy:a report of NABTT 96-07[J].J Clin Oncol,2003,21 (6):1044-1049.
  • 6Bataille B,Delwail V,Menet E,et al.Primary intracerebeal malignant lymphoma:report of 248 cases[J].J Neuroesurg,2000,92 (2):261-266.
  • 7Basso U,Brandes A A.Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma[J].Eur J Cancer,2002,38(10):1298-1312.
  • 8Shenkier T N,Blay J Y,O'Neill B P,et al.Primary CNS lymphoma of T-cell origin:a descriptive analysis from the international primary CNS lymphoma collaborative group[J].J Clin Oncol,2005,23 (10):2233-2239.
  • 9Sacktor N.The epidemiology of human immunodeficiency virusassociated neurological disease in the era of highly active antiretroviral therapy[J].J Neurovirol,2002,8 (Suppl 2):115-121.
  • 10Ferreri A J,Reni M,Villa E.Therapeutic management of primary central nervous system lymphoma:lessons from prospective trials[J].Ann Oncol,2000,11 (8):927-937.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部